Eszopiclone

Brand Names: Lunesta

Drug Class: Non-benzodiazepine hypnotic

Overview

Eszopiclone is a non-benzodiazepine hypnotic agent indicated for the treatment of insomnia. It decreases sleep latency and improves sleep maintenance, with clinical trials supporting efficacy for up to 6 months. The drug should be used at the lowest effective dose for the shortest duration necessary.

Mechanism of Action

Eszopiclone is a non-benzodiazepine hypnotic that acts as an agonist at the benzodiazepine receptor complex, which is part of the GABA-A receptor. This enhances GABA-mediated neuronal inhibition in the central nervous system, producing sedative and hypnotic effects.

Indications

  • Treatment of insomnia characterized by difficulties with sleep initiation and/or sleep maintenance

Common Doses

  • 1 mg
  • 2 mg
  • 3 mg

Dosage

Use the lowest effective dose for the patient. The recommended starting dose for most adults is 1 mg immediately before bedtime, which may be increased to 2-3 mg if clinically indicated. For elderly patients or those with hepatic impairment, the recommended starting dose is 1 mg.

Contraindications

  • Patients who have experienced complex sleep behaviors after taking eszopiclone
  • Patients with known hypersensitivity to eszopiclone (including anaphylaxis and angioedema)

Side Effects

  • Unpleasant taste
  • Headache
  • Somnolence
  • Dizziness
  • Dry mouth
  • Nausea
  • Next-day drowsiness
  • Complex sleep behaviors
  • Memory impairment
  • Hallucinations
  • Withdrawal symptoms upon discontinuation

Interactions

  • Alcohol (increased CNS depression)
  • Other CNS depressants (opioids, benzodiazepines, sedating antihistamines)
  • CYP3A4 inhibitors (ketoconazole, clarithromycin) may increase eszopiclone levels
  • CYP3A4 inducers (rifampin, carbamazepine) may decrease eszopiclone effectiveness

Counseling Points

  • Take immediately before bedtime with at least 7-8 hours remaining before planned awakening
  • Do not take with or immediately after a high-fat meal
  • Avoid alcohol and other CNS depressants
  • Report any complex sleep behaviors or unusual thoughts/behaviors
  • Do not drive or operate machinery until effects are known
  • Taper gradually if discontinuing after prolonged use